Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05020678
Title NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nkarta Inc.
Age Groups: adult | senior
Covered Countries USA | AUS

No variant requirements are available.